NEW
Stock Screener with Intrinsic Value
Protagonist Therapeutics, Inc. (PTGX)
Last Price$37.2(1.6%)
Market Cap$2,297.8M
99.2%
Industry median - 65.3%
5Y Historical average - 6.4%
53.5%
Industry median - (867.7%)
5Y Historical average - (3,185.7%)
70.8%
Industry median - (726.1%)
5Y Historical average - (1,998.6%)
134.2%
Industry median - 83.4%
5Y Historical average - 86.6%
PTGX Profitability Rating
Crunching data... Almost there!
PTGX Profitability Metrics
Crunching data... Almost there!
Competing with PTGX Profitability
Overview
Ratings
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Crunching data... Almost there!
FAQ
What is the Protagonist Therapeutics, Inc. (PTGX) gross profit margin?
The Protagonist Therapeutics, Inc. (PTGX) gross profit margin is 99.2%, compared to the industry median of 65.3% and the 5-year historical average of 6.4%.
What is the Protagonist Therapeutics, Inc. (PTGX) operating income margin?
The Protagonist Therapeutics, Inc. (PTGX) operating income margin is 53.5%, compared to the industry median of (867.7%)) and the 5-year historical average of (3,185.7%).
What is the Protagonist Therapeutics, Inc. (PTGX) Free Cash Flow (FCF) margin?
The Protagonist Therapeutics, Inc. (PTGX) Free Cash Flow margin is 70.8%, compared to the industry median of (726.1%) and the 5-year historical average of (1,998.6%).
What is the Protagonist Therapeutics, Inc. (PTGX) earnings quality?
The Protagonist Therapeutics, Inc. (PTGX) earnings quality is 134.2%, compared to the industry median of 83.4% and the 5-year historical average of 86.6%.